Regulus Therapeutics (RGLS)

Add to Watchlists
Create an Alert
8.61 +0.16  +1.89% NASDAQ Sep 4, 16:59 Delayed 2m USD
View Full Chart
RGLS Price Chart
View All Performance Charts

RGLS Total Returns Comparison

Advertisement

RGLS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.regulusrx.com
  • IR Website: http://ir.regulusrx.com/
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: June 30, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Regulus Therapeutics Inc is a biopharmaceutical company. The Company is engaged in discovering and developing drugs that target micro RNAs to treat various diseases.

RGLS Excel Add-In Codes

  • Name: =YCI("RGLS","name")
  • Description: =YCI("RGLS","description")
  • Sector: =YCI("RGLS","sector")
  • Industry: =YCI("RGLS","industry")
  • Est. Current Fiscal Year End: =YCI("RGLS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.